How does lung-cancer risk change after quitting smoking?

01

What the often-quoted 10–15 years actually describes

The 2020 US Surgeon General report concludes that the evidence supports a steady decline in relative lung-cancer risk after cessation: at roughly 10–15 years, it is about half that of people who continue smoking, with further decline during continued cessation. The reference group matters. This does not say ‘half your chance tomorrow’, ‘no benefit before year ten’ or ‘equal to a never-smoker’.

A summary interval describes evidence across groups. It is not a countdown starting from an individual's last cigarette, and does not supply the absolute number of people who will develop cancer. To understand an estimate, keep the outcome, comparison group and study population attached to the years.

[1]

02

One cohort, two answers at the same long interval

Tindle and colleagues' 2018 Framingham study followed two US cohorts through 2013, excluding lung cancer present at baseline. It recorded 284 new lung-cancer diagnoses over a median follow-up of 28.7 years. The principal adjusted comparisons below concerned participants with at least 21.3 cumulative pack-years, the study's exposure cut-point, not a clinical definition or a screening rule. Smoking status was updated every two or four years rather than assumed unchanged from enrolment.

Among former smokers at 25 years or more since quitting, the adjusted hazard ratio was 0.19 against continuing smokers but 3.85 against never-smokers. This is not a contradiction: changing the reference group changes the question. The first shows a lower hazard of new diagnoses relative to continuing; the second shows residual excess relative to never smoking. Neither ratio is an individual's chance of getting cancer.

The table reports model estimates and 95% confidence intervals, not lifetime probabilities or percentage points saved. These were observational cohorts, mainly white people of European ancestry in the northeastern US; not all influences, including some other exposures, were measured. The exact values cannot be assigned to every country, smoking history or person, and the study's historical screening discussion is not current eligibility advice.

[2]

03

Do not replace new diagnoses with a death statistic

Incidence asks about new lung-cancer diagnoses. Mortality asks about deaths from lung cancer. NCI's professional prevention summary describes a 30–60% reduction in lung-cancer mortality risk after ten years of cessation versus persistent smoking. It labels that endpoint mortality; it must not be silently rewritten as an incidence percentage or spliced into the cohort table to create a single recovery curve.

The Framingham comparisons also are not survival estimates for someone already diagnosed. Research on people previously treated for cancer or on a later primary tumour has a different starting population and question. A scan, nodule, personal symptom or existing diagnosis cannot be interpreted using these group ratios; it belongs with qualified care.

[2][3]

04

Use the benefit without demanding a personal clearance date

The practical message is positive: remaining above a never-smoker comparison does not erase the benefit relative to continued smoking. When reading ‘risk halves’, ask ‘which outcome, compared with whom, and in which population?’ If those details are absent, the headline cannot tell you your own risk or whether an examination is needed. You do not need a cancer-risk score to ask for help staying away from cigarettes.

In England, NHS guidance points to local stop-smoking support; personal questions about investigations or existing care go to the appropriate clinical professional. This page offers no risk calculator and receives no smoking history, quit date, scan or diagnosis. A private note of a source and its comparison can help you discuss a claim without posting health details publicly.

[1][2][4]

05

What to keep in mind

• Cessation benefit and residual risk can both be real.
• Keep incidence, mortality and post-diagnosis outcomes separate.
• Study years and ratios are not your screening or clearance date.